Mineralocorticoid receptor blockers for moderate kidney dysfunction: more merit than ever?
Hypertens Res
.
2021 Oct;44(10):1352-1354.
doi: 10.1038/s41440-021-00690-6.
Epub 2021 Jul 15.
Authors
Masashi Mukoyama
1
,
Takashige Kuwabara
2
,
Masataka Adachi
2
Affiliations
1
Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan. mmuko@kumamoto-u.ac.jp.
2
Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.
PMID:
34267356
DOI:
10.1038/s41440-021-00690-6
No abstract available
Publication types
Editorial
MeSH terms
Humans
Kidney
Mineralocorticoid Receptor Antagonists / therapeutic use*
Receptors, Mineralocorticoid
Renal Insufficiency* / drug therapy
Substances
Mineralocorticoid Receptor Antagonists
Receptors, Mineralocorticoid